Dual targeting of hepatocyte DGAT2 and stellate cell FASN alleviates nonalcoholic steatohepatitis in mice.
Yenilmez, B.; Harney, S. M.; DiMarzio, C.; Kelly, M.; Min, K.; Echeverria, D.; Bramato, B. M.; Jackson, S. O.; Reddig, K.; Kim, J. K.; Khvorova, A.; Czech, M. P.
Show abstract
Nonalcoholic steatohepatitis (NASH) is a malady of multiple cell types associated with hepatocyte triglyceride (TG) accumulation, macrophage inflammation, and stellate cell-induced fibrosis, with no approved therapeutics yet available. Here, we report that stellate cell fatty acid synthase (FASN) in de novo lipogenesis drives the autophagic flux that is required for stellate cell activation and fibrotic collagen production. Further, we employ a dual targeting approach to NASH that selectively depletes collagen through selective stellate cell knockout of FASN (using AAV9-LRAT Cre in FASNfl/fl mice), while lowering hepatocyte triglyceride by depleting DGAT2 with a GalNac-conjugated, fully chemically modified siRNA. DGAT2 silencing in hepatocytes alone or in combination with stellate cell FASNKO reduced liver TG accumulation in a choline-deficient NASH mouse model, while FASNKO in hepatocytes alone (using AAV8-TBG Cre in FASNfl/fl mice) did not. Neither hepatocyte DGAT2 silencing alone nor FASNKO in stellate cells alone decreased fibrosis (total collagen), while loss of both DGAT2 plus FASN caused a highly significant attenuation of NASH. These data establish proof of concept that dual targeting of DGAT2 plus FASN alleviates NASH progression in mice far greater than targeting either gene product alone.
Matching journals
The top 16 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis 99%
- Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis 96%
- Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice 96%
Similar papers in this journal
- Mendelian Randomization Analysis Dissects the Relationship between NAFLD, T2D, and Obesity and Provides Implications to Precision Medicine 94%
- 24-Nor-Ursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation 94%
- A Human Liver Organoid Screening Platform for DILI Risk Prediction 93%
Similar papers in this journal
- Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity 95%
- Reduced ZMPSTE24 expression leads to prelamin accumulation and development of steatosis in MASLD patients. 94%
- SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation 93%
Similar papers in this journal
- MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retention 96%
- Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells 94%
- Liver-innervating vagal sensory neurons play an indispensable role in the development of hepatic steatosis and anxiety-like behavior in mice fed a high-fat diet. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.